ASCENDIS HEALTH LIMITED - ASC/ ASCN - Dealings in securities by Directors

Release Date: 05/08/2016 14:13
Code(s): ASC ASCN
Wrap Text
ASC/ ASCN - Dealings in securities by Directors

(Incorporated in the Republic of South Africa)
(Registration number 2008/005856/06)
ISIN: ZAE000185005 Share code: ASC
ISIN: ZAE000221891 Share Code: ASCN
(“Ascendis” or the “Company”)


In accordance with sections 3.63 to 3.74 of the Listings Requirements of the JSE
Limited, shareholders are advised of dealings in securities by the directors of Ascendis
as indicated below.

Name of Company:                 Ascendis Health Limited
Name of director:                Dr. Karsten Wellner, Chief Executive Officer
Class of securities:             Nil paid letters in terms of the rights offer
Nature of transaction:           On market sale of remaining nil paid letters (NPL) after
                                 receiving funding to follow over 90% of his total rights
                                 in the rights offer
Nature of interest:              Direct beneficial
Date of transaction:             29 July 2016
Number of securities:            45,455
Highest Price per NPL:           R1.76
Lowest Price per NPL:            R1.70
Total value of transactions:     R77,826.46

The Ascendis director obtained clearance to trade in terms of section 3.66 of the
Listings Requirements.

5 August 2016

Transaction Sponsor
Absa Bank Limited (acting through its Corporate and Investment Bank division)

Investec Bank Limited

Date: 05/08/2016 02:13:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Email this JSE Sens Item to a Friend.

Share This Story